Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians

Benjamin Arko-Boham, E. Tagoe, BerniceAdjorogbe, N. Aryee, S. M. Adadey, O. Quaye, J. Clegg-Lamptey
{"title":"Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians","authors":"Benjamin Arko-Boham, E. Tagoe, BerniceAdjorogbe, N. Aryee, S. M. Adadey, O. Quaye, J. Clegg-Lamptey","doi":"10.4172/CLINICAL-INVESTIGATION.1000120","DOIUrl":null,"url":null,"abstract":"Background: Glutathione S-transferase (GST) gene polymorphism has been associated with breast cancer; however, there are conflicting results. Little or no information exists in the Ghanaian population. Aim: To determine the association between GST polymorphic genes (GSTM1 and GSTT1) and susceptibility to breast cancer in Ghanaian population. Method: 112 whole blood samples were retrieved from -80oC freezer. Samples comprised 56 female breast cancer patients. Demographic and clinical data were retrieved from records. Patients were age matched with 56 controls. Genomic DNA was extracted; GSTTI and GSTM1 genes amplified using multiplex PCR with appropriate primers and the resultant amplicons separated by agarose gel electrophoresis. Results: The prevalence of GSTT1 null in patients was 42.9% and with greater association with breast cancer (OR=2.84, 95% CI=1.52–5.29, p=0.001). The heterozygous GSTT1 null/GSTM1 genotype was strongly associated with breast cancer (OR=3.02, 95% CI=1.61–5.66, p 0.05). However, the presence of both genes was not a risk factor of breast cancer in the patients (OR=0.53, 95% CI=0.28–1.09, p=0.030). Conclusion: The GSTT1 null and GSTT1 null / GSTM1 genotypes may be potential risk factors for breast cancer susceptibility.","PeriodicalId":10369,"journal":{"name":"Clinical investigation","volume":"6 1","pages":"119-125"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/CLINICAL-INVESTIGATION.1000120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Glutathione S-transferase (GST) gene polymorphism has been associated with breast cancer; however, there are conflicting results. Little or no information exists in the Ghanaian population. Aim: To determine the association between GST polymorphic genes (GSTM1 and GSTT1) and susceptibility to breast cancer in Ghanaian population. Method: 112 whole blood samples were retrieved from -80oC freezer. Samples comprised 56 female breast cancer patients. Demographic and clinical data were retrieved from records. Patients were age matched with 56 controls. Genomic DNA was extracted; GSTTI and GSTM1 genes amplified using multiplex PCR with appropriate primers and the resultant amplicons separated by agarose gel electrophoresis. Results: The prevalence of GSTT1 null in patients was 42.9% and with greater association with breast cancer (OR=2.84, 95% CI=1.52–5.29, p=0.001). The heterozygous GSTT1 null/GSTM1 genotype was strongly associated with breast cancer (OR=3.02, 95% CI=1.61–5.66, p 0.05). However, the presence of both genes was not a risk factor of breast cancer in the patients (OR=0.53, 95% CI=0.28–1.09, p=0.030). Conclusion: The GSTT1 null and GSTT1 null / GSTM1 genotypes may be potential risk factors for breast cancer susceptibility.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加纳乳腺癌易感人群谷胱甘肽s -转移酶T1和M1基因多态性
背景:谷胱甘肽s -转移酶(GST)基因多态性与乳腺癌有关;然而,结果却相互矛盾。关于加纳人口的信息很少或根本没有。目的:确定GST多态性基因(GSTM1和GSTT1)与加纳人群乳腺癌易感性之间的关系。方法:从-80℃冷冻库中采集全血112份。样本包括56名女性乳腺癌患者。从记录中检索人口统计学和临床数据。患者与56名对照者年龄匹配。提取基因组DNA;GSTTI和GSTM1基因用多重PCR扩增,用合适的引物扩增,所得扩增子用琼脂糖凝胶电泳分离。结果:患者中GSTT1 null的患病率为42.9%,与乳腺癌的相关性更大(OR=2.84, 95% CI= 1.52-5.29, p=0.001)。杂合子GSTT1 null/GSTM1基因型与乳腺癌密切相关(OR=3.02, 95% CI=1.61 ~ 5.66, p 0.05)。然而,这两个基因的存在并不是患者患乳腺癌的危险因素(OR=0.53, 95% CI= 0.28-1.09, p=0.030)。结论:GSTT1缺失和GSTT1缺失/ GSTM1基因型可能是乳腺癌易感性的潜在危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Targeting TGF-beta pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19 A Prospective on Allergic Rhinitis Use of Cladribine for multiple sclerosis treatment: An image article Thalidomide may be an effective medicine for Blau Syndrome Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1